Cargando…

Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer

Oxaliplatin resistance is one of the main causes of failed colorectal cancer treatment, followed by recurrence and metastasis. In this study, we found that colorectal cancer cells secrete a high level of hyaluronic acid (HA), which interacts with its receptor CD44v6 to mediate colorectal cancer resi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Wenlong, Yang, Xiaoping, He, Shenfu, Wang, Jia, Guo, Yuanxian, Kou, Bangguo, Jiang, Yongjie, Bian, Pan, Li, Bingtai, Yin, Lanning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118506/ https://www.ncbi.nlm.nih.gov/pubmed/33974471 http://dx.doi.org/10.1080/10717544.2021.1914777

Ejemplares similares

Hyaluronic Acid–Zein Core-Shell Nanoparticles Improve the Anticancer Effect of Curcumin Alone or in Combination with Oxaliplatin against Colorectal Cancer via CD44-Mediated Cellular Uptake
por: Liu, Lu, et al.
Publicado: (2022)

Primary neuroendocrine carcinoma of the breast with markedly elevated alpha-fetoprotein: a case report
por: Wang, Jia, et al.
Publicado: (2021)

CD44-Targeted Carriers: The Role of Molecular Weight of Hyaluronic Acid in the Uptake of Hyaluronic Acid-Based Nanoparticles
por: Chiesa, Enrica, et al.
Publicado: (2022)

Hyaluronic Acid-Decorated Chitosan Nanoparticles for CD44-Targeted Delivery of Everolimus
por: Chiesa, Enrica, et al.
Publicado: (2018)

Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition
Publicado: (1990)

A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid
Publicado: (1996)

Identification of hyaluronic acid binding sites in the extracellular domain of CD44
Publicado: (1993)

MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
por: Yang, Xiaoqian, et al.
Publicado: (2015)

Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells
por: Hayward, Stephen L., et al.
Publicado: (2016)

CD44H regulates tumor cell migration on hyaluronate-coated substrate
Publicado: (1992)

Hyaluronate Fragments Reverse Skin Atrophy by a CD44-Dependent Mechanism
por: Kaya, Gürkan, et al.
Publicado: (2006)

Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity
Publicado: (1996)

Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain
Publicado: (1995)

Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development
Publicado: (1994)

CD44 Binding to Hyaluronic Acid Is Redox Regulated by a Labile Disulfide Bond in the Hyaluronic Acid Binding Site
por: Kellett-Clarke, Helena, et al.
Publicado: (2015)

HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44
por: Yang, Bo, et al.
Publicado: (2023)

Hyaluronic acid–nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo
por: Jian, You-Sin, et al.
Publicado: (2017)

Smart Nanoparticles Based on Hyaluronic Acid for Redox-Responsive and CD44 Receptor-Mediated Targeting of Tumor
por: Park, Hyung-Kyu, et al.
Publicado: (2015)

Engineering hyaluronic acid-based cryogels for CD44-mediated breast tumor reconstruction
por: Rezaeeyazdi, Mahboobeh, et al.
Publicado: (2022)

Hyaluronic Acid-Based Nanosystems for CD44 Mediated Anti-Inflammatory and Antinociceptive Activity
por: Salathia, Saniya, et al.
Publicado: (2023)

Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
por: Zhou, Yue, et al.
Publicado: (2022)

Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44(+) cancer cells
por: Shabani Ravari, Nazanin, et al.
Publicado: (2016)

Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition
Publicado: (1992)

Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody
Publicado: (1992)

Hyaluronic Acid (Ha) Binding to Cd44 Activates Rac1 and Induces Lamellipodia Outgrowth
por: Oliferenko, Snezhana, et al.
Publicado: (2000)

Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery
por: Yang, Yishun, et al.
Publicado: (2018)

Hyaluronic-Acid-Tagged Cubosomes Deliver Cytotoxics Specifically to CD44-Positive Cancer Cells
por: Pramanik, Arindam, et al.
Publicado: (2022)

Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
por: Zhou, Yue, et al.
Publicado: (2022)

Assessment of Oxaliplatin-Loaded Iodine Nanoparticles for Chemoradiotherapy of Human Colorectal Cancer (HT-29) Cells
por: Rasouli, Naser, et al.
Publicado: (2022)

On-Chip Synthesis of Hyaluronic Acid-Based Nanoparticles for Selective Inhibition of CD44+ Human Mesenchymal Stem Cell Proliferation
por: Chiesa, Enrica, et al.
Publicado: (2020)

Receptor-Meditated Endocytosis by Hyaluronic Acid@Superparamagnetic Nanovetor for Targeting of CD44-Overexpressing Tumor Cells
por: Yu, Kwang Sik, et al.
Publicado: (2016)

Preparation, Characterization, and Inhibition of Hyaluronic Acid Oligosaccharides in Triple-Negative Breast Cancer
por: Han, Wenwei, et al.
Publicado: (2019)

Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
por: Liang, Ye, et al.
Publicado: (2020)

Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function
Publicado: (1994)

Synergistic Effect of Hyaluronate Fragments in Retinaldehyde-Induced Skin Hyperplasia Which Is a Cd44-Dependent Phenomenon
por: Barnes, Laurent, et al.
Publicado: (2010)

Editorial: Interaction Between Hyaluronic Acid and Its Receptors (CD44, RHAMM) Regulates the Activity of Inflammation and Cancer
por: Naor, David
Publicado: (2016)

Novel Hyaluronic Acid Conjugates for Dual Nuclear Imaging and Therapy in CD44-Expressing Tumors in Mice In Vivo
por: Dubey, Ravindra Dhar, et al.
Publicado: (2017)

Molecular weight of surface immobilized hyaluronic acid influences CD44-mediated binding of gastric cancer cells
por: Amorim, Sara, et al.
Publicado: (2018)

Role of CD44 in increasing the potency of mesenchymal stem cell extracellular vesicles by hyaluronic acid in severe pneumonia
por: Zhou, Li, et al.
Publicado: (2021)

Quercetin-solid lipid nanoparticle-embedded hyaluronic acid functionalized hydrogel for immunomodulation to promote bone reconstruction
por: Zhou, Pinghui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_emsdr513b7dslsuc085lrhlkj1